MoneyWorks4Me

Supriya Lifescience - Quaterly Results

28 Oct 2024 Evaluate
A fair growth of 18.56% in the revenue at Rs. 1661.02 millions was reported in the September 2024 quarter as compared to Rs. 1400.95 millions during year-ago period.The Profit  for the quarter ended September 2024 of  Rs. 461.49  millions  grew by 93.22% from Rs. 238.84 millions.Operating Profit saw a handsome growth to 672.35 millions from 342.19 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 1661.02 1400.95 18.56 3267.28 2721.16 20.07 5703.70 4609.38 23.74
Other Income 25.18 24.67 2.07 47.42 53.85 -11.94 106.35 94.89 12.08
PBIDT 672.35 342.19 96.48 1320.01 816.28 61.71 1836.11 1383.87 32.68
Interest 4.27 4.60 -7.17 7.62 12.76 -40.28 21.10 30.84 -31.58
PBDT 668.08 337.59 97.90 1312.39 803.52 63.33 1815.01 1353.03 34.14
Depreciation 47.44 39.81 19.17 94.00 79.36 18.45 158.11 118.15 33.82
PBT 620.64 297.78 108.42 1218.39 724.16 68.25 1656.90 1234.88 34.17
TAX 159.15 58.94 170.02 310.46 200.20 55.07 465.76 336.30 38.50
Deferred Tax 4.69 -26.44 -117.74 9.33 15.19 -38.58 94.76 29.49 221.33
PAT 461.49 238.84 93.22 907.93 523.96 73.28 1191.14 898.58 32.56
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 40.48 24.43 65.72 40.40 30.00 34.68 32.19 30.02 7.22
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..